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Abstract
The insulin/IGF signaling pathway is a highly conserved regulator of metabolism in flies and mammals, regulating multiple
physiological functions including lipid metabolism. Although insulin signaling is known to regulate the activity of a number
of enzymes in metabolic pathways, a comprehensive understanding of how the insulin signaling pathway regulates
metabolic pathways is still lacking. Accepted knowledge suggests the key regulated step in triglyceride (TAG) catabolism is
the release of fatty acids from TAG via the action of lipases. We show here that an additional, important regulated step is the
activation of fatty acids for beta-oxidation via Acyl Co-A synthetases (ACS). We identify pudgy as an ACS that is
transcriptionally regulated by direct FOXO action in Drosophila. Increasing or reducing pudgy expression in vivo causes a
decrease or increase in organismal TAG levels respectively, indicating that pudgy expression levels are important for proper
lipid homeostasis. We show that multiple ACSs are also transcriptionally regulated by insulin signaling in mammalian cells.
In sum, we identify fatty acid activation onto CoA as an important, regulated step in triglyceride catabolism, and we identify
a mechanistic link through which insulin regulates lipid homeostasis.
Citation: Xu X, Gopalacharyulu P, Seppa¨nen-Laakso T, Ruskeepa¨a¨ A-L, Aye CC, et al. (2012) Insulin Signaling Regulates Fatty Acid Catabolism at the Level of CoA
Activation. PLoS Genet 8(1): e1002478. doi:10.1371/journal.pgen.1002478
Editor: Eric Rulifson, University of California San Francisco, United States of America
Received June 23, 2011; Accepted November 30, 2011; Published January 19, 2012
Copyright:  2012 Xu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was conducted as part of the MITIN project and partially funded by the European Commission under the 7th Framework Programme (Grant
no. HEALTH-F4-2008-223450) (http://cordis.europa.eu/fp7/home_en.html). BPC was supported by a Diabetes UK grant to SM (grant number 06/0003416) (http://
www.diabetes.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: a.teleman@dkfz.de
Introduction
The insulin/IGF signaling (IIS) pathway is a highly conserved
and critical regulator of metabolism in mammals and in flies,
where it senses organismal nutrient levels to regulate multiple
physiological functions including carbohydrate metabolism, tissue
growth and longevity [1–3]. Insulin regulates carbohydrate
metabolism by controlling expression and activity of a number
of metabolic enzymes such as phosphofructokinase-2, PEPCK,
Glycogen synthase and Glycogen phosphorylase [4]. Conditions of
altered insulin signaling are associated not only with changes in
carbohydrate metabolism, but also with abnormal lipid metabo-
lism, as in the cases of Type 2 Diabetes-associated obesity and
Non-Alcoholic Hepatic Steatosis [5,6]. A large body of evidence
suggests that insulin resistance plays a central, causal role in the
development of the lipid imbalances observed in both of these
conditions [5,6], however the molecular mechanisms leading to
these lipid imbalances are not completely understood. This raises
the need to better understand the molecular connections between
insulin signaling and lipid metabolism.
The molecular relationship between insulin signaling and lipid
homeostasis is complex, as dyslipidemia is considered to be both a
cause and a consequence of insulin resistance [6]. That said, IIS
clearly plays a causative role in regulating the balance of lipid
production versus breakdown in animals, since mice and flies in
which IIS has been specifically manipulated have altered lipid
metabolism ([7,8] and reviewed in [9–11]). The molecular
mechanisms by which IIS regulates lipid metabolism are only
partially understood. On the one hand, IIS promotes fatty acid
biosynthesis [12,13]. On the other, IIS regulates fatty acid
catabolism [13,14]. Fatty acid catabolism is a multi-step process
(Figure 1A). First, fatty acids are mobilized from stored
triacylglycerols (TAG) via the activity of lipases to yield free fatty
acids. Second, the free fatty acids are activated by coupling to
Coenzyme A (CoA). This step is catalyzed by the acyl-CoA
synthetase (ACS) family of enzymes. Third, the free fatty acids are
imported into mitochondria. Finally, in mitochondria, the fatty
acids are oxidized, yielding energy. Some of the steps in this
catabolic pathway are known to be regulated by IIS. For instance,
IIS inhibits expression and activity of lipases such as adipose
triglyceride lipase and hormones sensitive lipase [15,16]. IIS also
decreases the rate of fatty acid entry into mitochondria [17] in part
via a FoxO-dependent process [18]. A complete molecular
understanding of how IIS regulates fatty acid catabolism, however,
is currently lacking.
The upstream signaling events of the IIS pathway are fairly well
characterized. Activation of insulin/IGF receptor(s) leads to a
relay of phosphorylation events activating a number of kinases
including PI3K, Akt/PKB, TOR-C1 and S6K, thereby inhibiting
a key transcription factor FOXO (for review [19]). A challenge in
the field remains, however, to obtain a complete understanding of
how these upstream ‘signaling’ components of the IIS pathway
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link to, and regulate, the metabolic biochemical pathways
controlling cellular metabolism. Discovering the connections
between the signaling components of the insulin pathway and
the metabolic enzymes controlling cellular biochemical pathways
remains an important step in understanding how IIS controls
metabolism generally, and lipid metabolism in particular.
We identify here an ACS which we term pudgy, as a gene
that is strongly upregulated upon fasting in Drosophila. We find
that pudgy is a target of the insulin signaling pathway, as its
expression is suppressed by insulin signaling, as a consequence
of direct regulation by FOXO. We find that animals with
reduced levels of pudgy expression are hyper-triglyceridemic and
have defects in their lipid usage upon fasting. This suggests that
in order to effectively channel fatty acids towards beta-
oxidation upon fasting conditions, organisms need to induce
both the lipolysis of fatty acids from TAG, as well as the
activation of fatty acids at mitochondria for beta-oxidation.
Finally, we show that expression of multiple mammalian ACSs
are also regulated by insulin signaling in mouse muscle, liver
and adipose cells. In sum, this work uncovers fatty acid
activation by ACSs as a novel and important insulin-regulated
step in TAG catabolism.
Results
The Acyl-CoA Synthetase pudgy is a direct FOXO target
We previously studied the transcriptional output of insulin
signaling in Drosophila by performing microarray analyses on
fasted versus fed animals [20]. By comparing wildtype versus
FOXO mutant animals, we pinpointed genes that are regulated in
a FOXO-dependent manner [20]. In this and similar studies by
other groups [21–24], a number of acyl-CoA synthetases (ACSs)
were found to be regulated by nutrient status. In particular, the
ACS gene CG9009 emerged in our analysis as a strongly regulated
gene, which we characterize further here.
Quantitative RT-PCR analysis on wildtype larvae shows that
expression of CG9009, which we term here pudgy (pdgy), is very
strongly up-regulated in the fat body upon 18 hours of fasting,
increasing 110-fold (Figure 1B). (The Drosophila fat body
performs the functions of mammalian adipose tissue and liver
combined.) In contrast, in FOXO21/25 null mutant larvae,
expression of pudgy only increases 3.4-fold in the fat body upon
fasting, indicating that the up-regulation of pudgy is strongly
FOXO dependent (Figure 1C, note different scale compared to
Figure 1B). Pudgy expression behaved similarly in muscle
(Figures 1B and 1C).
Pudgy expression could either be regulated directly or indirectly
by FOXO. To distinguish these possibilities, we performed a
bioinformatic scan of the promoter region of the pudgy gene, as we
previously showed that functional FOXO binding sites in
Drosophila are usually clustered within a few kilobases of the
transcription start site of regulated genes [20]. The pudgy promoter
region had a significant number of consensus FOXO binding sites
– 3 perfect (GTAAACAA) and 3 imperfect (1 mismatch in the 1st
or 2nd position) (indicated by asterisks in Figure 1D). We first tested
whether this region is able to serve as a FOXO-responsive cis-
regulatory enhancer element. Test genomic regions were linked to
a basal promoter directing luciferase expression in S2 cells. As a
positive control, a genomic region of the 4E-BP gene, an
established direct target of FOXO [25,26], was able to induce
luciferase activity in response to FOXO expression (Figure 1E).
Likewise, an 800 bp fragment of the pudgy region, containing 3 of
the 6 FOXO binding sites, induced luciferase activity in response
to FOXO expression (Figure 1E), suggesting it is a bona fide
FOXO response element. Next, to test whether endogenous
FOXO binds these sites in vivo, we performed chromatin
immunoprecipitations (ChIP) of endogenous FOXO from 3rd
instar larvae. We performed two negative controls: a mock ChIP
using pre-immune serum on wildtype larval lysates, as well as a
ChIP using anti-FOXO antibody [26] on lysates of FOXO21/25
null mutant larvae (Figure 1F) [23]. Quantitative PCR on the
immunoprecipitated material revealed that the promoter region of
4E-BP was strongly enriched in the FOXO ChIP from wildtype
larvae compared to the negative control ChIPs (ttest,0.001,
Figure 1F, black bars versus grey bars). Likewise, two test regions
in the first intron of pudgy, P1 and P2 (Figure 1D), were also
significantly enriched in the FOXO ChIP compared to the
negative control ChIPs (ttest,0.05 for P1 and ttest,0.01 for P2,
Figure 1F). As negative controls, the genomic regions of mir-278
and sty were not enriched in the FOXO ChIP compared to control
ChIPs (Figure 1F). Together, these data indicate that FOXO binds
the pudgy promoter region in vivo. In sum, this identifies pudgy is a
bona fide direct FOXO target.
Since FOXO activity is repressed by insulin signaling, pudgy
expression should also be repressed by insulin. Indeed, pudgy
expression was reduced in explants of both fat body tissue and
muscle tissue when they were treated with insulin (ttest,0.001,
Figure 1G). Moreover, in vivo, insulin signaling drops when larvae
have terminated feeding and start wandering out of the food.
Consistent with this, pudgy expression was 4-fold higher in
wandering 3rd instar larvae (wL3) compared to feeding 3rd instar
larvae (fL3) (Figure 1H).
Pudgy is an Acyl-CoA Synthetase associated with
mitochondria
Previous computational analyses identified CG9009/pudgy as a
gene encoding an acyl-CoA synthetase (ACS) [27]. ACSs are a
family of enzymes which activate free fatty acids for subsequent
anabolic or catabolic reactions by loading them onto CoA. Each
member of this family has distinct substrate specificity, loading
fatty acid molecules of different lengths or saturation onto CoA
[27]. In addition, each member of the ACS family has a distinct
intracellular localization. This is particularly relevant in lieu of that
fact that subsequent reactions involving activated acyl-CoA
molecules take place in distinct subcellular compartments. Fatty
acid oxidation occurs either in mitochondria in the form of beta-
oxidation, or in peroxisomes. In contrast, anabolic reactions take
place predominantly in the cytoplasm or endoplasmic reticulum.
Author Summary
Type 2 diabetes, which is reaching epidemic proportions
worldwide, is often associated with obesity and an
imbalance in organismal lipid homeostasis. Therefore,
understanding how insulin regulates lipid biosynthesis
and breakdown is necessary. Surprisingly, the molecular
mechanisms by which insulin regulates fatty acid catabo-
lism are not entirely understood. We show here that insulin
signaling regulates expression of acyl-CoA Synthetases
(ACS). ACSs couple fatty acids to Coenzyme A, thereby
activating them for subsequent biochemical reactions. In
Drosophila, we find that insulin signaling modulates
expression of one ACS called Pudgy, which activates fatty
acids for beta-oxidation. Modulation of pudgy expression
leads to changes in overall organismal lipid homeostasis.
Likewise, we show that in mammalian cells insulin
signaling regulates expression of a number of ACSs and
that ACS expression modulates steady-state lipid levels.
Insulin Regulates ACS Expression
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Figure 1. Pudgy is a direct FOXO target, upregulated upon fasting. (A) Simplified schematic of triacylglycerol catabolism. Triacylglycerides
(TAG) are cleaved by lipases, releasing free fatty acids (free FA). These are linked to CoA by acyl-CoA synthetases (ACSs). Acyl-CoA moities are then
either oxidized via beta-oxidation or used for biosynthetic reactions. (B,C) pudgy expression is upregulated in a FOXO-dependent manner upon
nutrient withdrawal in 3rd instar larvae. Control (B) or FOXO21/25 null mutants (C) were either fed or deprived of food for 18 hours, and expression of
pudgy in fat body or muscle analyzed by quantitative RT-PCR relative to rp49. (D) Schematic of pudgy (pdgy, CG9009) genomic locus. Site of the P-
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Thus the subcellular localization of each member of the ACS
family may influence the fate of the acyl-CoA molecules that it
generates [28]. By channeling fatty acids towards downstream
anabolic or catabolic processes, ACSs such as Pudgy have the
potential to influence the fate of the fatty acids and the overall
balance of organismal lipid homeostasis [29], a hypothesis which
we test here.
To confirm that the protein encoded by pudgy is indeed an ACS,
we recombinantly expressed and purified His-tagged pudgy from
E. coli and found that it has acyl-CoA synthetase activity in vitro
(Figure 2A). Pudgy is expressed in all tissues of the larva that we
tested (Figure 2B). Since the localization of ACSs influences their
function, we investigated the subcellular localization of pudgy.
Expression of a C-terminal epitope-tagged version of pudgy in S2
cells revealed that it co-localizes with a GFP construct marking
mitochondria (mitoGFP) (Figure 2C), suggesting pudgy may load
fatty acids onto CoA for mitochondrial beta-oxidation (see below).
To study the physiological role of pudgy, we obtained flies
containing a transposon insertion in the 59 UTR of pudgy
(P{GT1}BG02662, ‘‘pdgy[BG]’’, Figure 1D). The pdgy[BG] muta-
tion was back-crossed into the w1118 background for five
generations (via females) in order to obtain two stocks with similar
genetic backgrounds, differing by presence or absence of the
pdgy[BG] mutation. The resulting stock carrying the pdgy[BG]
mutation in the w1118 background was used for all subsequent
experiments described here, and will be referred to as pdgy[BG]
mutant flies, whereas the w1118 flies will be referred to as controls.
pdgy[BG] homozygous larvae and adults have strongly reduced
expression of pudgy, measured by quantitative RT-PCR (Figure 2D
and 2D9 respectively). We believe this animal model may not
represent a complete pudgy null situation, but is a good model for
studying the physiological effects of strongly reduced pudgy
function. To test whether pudgy is involved in fatty acid oxidation,
we measured oxygen consumption in control and pdgy[BG] mutant
larvae using a Clark electrode. In the absence of drugs, oxygen
consumption in pdgy[BG] mutant larvae was significantly reduced
compared to controls (Figure 2E). Subsequent addition of
etomoxir, a specific inhibitor of Carnitine palmitoyltransferase I
(CPTI) [30], required for the transport of fatty acids into
mitochondria where beta-oxidation takes place, causes this
difference in oxygen consumption to be abrogated (300 mM
etomoxir, Figure 2E). This indicates that the difference in oxygen
consumption between pdgy[BG] mutants and controls is due to
differential mitochondrial lipid oxidation. Subtraction of the basal
rate of oxygen consumption in the presence of 300 mM etomoxir
from the oxygen consumption in the absence of etomoxir, yields
the rate of CPTI-dependent oxygen consumption, revealing that
pdgy[BG] mutants have significantly reduced ß-oxidation levels
compared to controls (Figure 2E9). Conversely, overexpression of
pudgy in larvae was sufficient to increase the rate of fatty acid
beta-oxidation (Figure S1).
Pudgy expression levels regulate organismal lipid
homeostasis
The above-mentioned data indicate that insulin/IGF signaling
modulates pudgy expression in vivo. Therefore, we asked whether
modulation of pudgy expression has an impact on organismal lipid
homeostasis. We first tested the effect of increasing pudgy
expression. Ubiquitous over-expression of pudgy from a transgene
using the GAL4/UAS system [31] was sufficient to cause a
significant reduction in organismal triglyceride levels both in
larvae and in adults (Figure 3A and 3A9 respectively). pdgy[BG]
homozygous mutants are viable, fertile, and normally patterned
(Figure S2A). Conversely to pudgy gain-of-function, pdgy[BG]
mutant larvae and adults have significantly elevated triglyceride
levels compared to controls (Figure 3B and 3B9 respectively). This
phenotype was fully rescued in larvae and partially rescued in
adults by introducing UAS-pudgy into the pdgy[BG] mutants, since
the pdgy[BG] insertion is a GAL4 gene trap resulting in both pudgy
loss-of-function as well as GAL4 expression (Figure 3B and 3B9). A
comprehensive lipidomic analysis using Ultra Performance Liquid
Chromatography coupled to mass spectrometry (UPLC-MS) of
molecular lipid species in pdgy[BG] mutant versus control flies
revealed that many, but not all, triglyceride species were
significantly elevated in pdgy[BG] mutant adults (Table S1). The
results for the 20 most abundant TAGs are shown in Figure 3C. In
addition, levels of some other complex lipids, such as cholesteryl
ester (19:0), were also elevated in pdgy[BG] mutants (Table S1).
The increased adiposity of pdgy[BG] mutants is consistent with the
reduced levels of fatty acid oxidation observed in these animals
(Figure 2E and 2E9). Furthermore, Pudgy mutants do not ingest
more than control animals (Figure S3A and S3A9) and have
reduced expression of key lipogenic genes such as Acetyl-CoA
Carboxylase (ACC) and Fatty Acid Synthase (FAS) (Figure S3B
and S3B9), suggesting that mutant animals may be trying to
compensate for their increased adiposity. These results are
analogous to those observed in ACSL1 knockout mice, which
have elevated fat mass [32]. Together, they indicate that the level
of expression of ACSs is important for setting steady-state lipid
levels both in flies and in mammals.
Pudgy mutant flies have an altered lipid catabolic profile
upon fasting
We next studied the physiological consequences of impaired
pudgy expression in flies upon fasting. Upon complete food
withdrawal, pdgy[BG] mutants survived significantly longer com-
pared to controls (Figure 4A and Figure S3C). This is likely due in
part to the increased adiposity of pdgy[BG] mutants, as starvation
survival is known to correlate with lipid levels in the fly [25,33–35].
Additionally, this could also be due in part to a reduced rate of
lipid catabolism which is nonetheless sufficient to support viability.
We therefore tested whether lipid catabolism might also be
impaired in pdgy[BG] mutants, as they have reduced fatty acid
element P{GT1}BG02662 insertion in the 59UTR of pdgy is indicated. Asterisks: FOXO binding sites. P1 and P2: amplicons tested in the FOXO chromatin
IP in panel F. (E) Luciferase assay testing FOXO-responsiveness of genomic enhancers. Genomic fragments containing the FOXO enhancer of the
bona-fide FOXO target 4E-BP (4EBP.Luc), or containing three of the FOXO binding sites in pudgy intron 1 (pudgy.Luc) were introduced into a
luciferase vector containing a basal promoter and firefly luciferase (+.Luc). Relative luciferase induction in the presence versus absence of FOXO
expression is indicated, normalized to a renilla luciferase control. (F) FOXO binds the pudgy promoter region. Quantification by Q-PCR of chromatin
immunoprecipitated (ChIP) material from FOXO mutant animals using anti-FOXO antibody (‘‘FOXO mutant’’, a negative control) or from wildtype
animals using either pre-immune serum (‘‘mock ChIP’’, a negative control) or anti-FOXO antibody (‘‘FOXO ChIP’’). Promoter regions assayed were
those of 4E-BP (a direct FOXO target), mir-278 and sty (two negative controls) and two regions of the first intron of pudgy, P1 and P2, as indicated in
Panel D. (G) Insulin signaling represses pudgy expression in fat body and muscle. Pudgy expression in tissues explanted from feeding 3rd instar larvae
treated in Schneider’s medium with or without 10 mg/ml insulin for 30 min, quantified by Q-RT-PCR relative to rp49. (H) pudgy expression increases in
third instar larvae upon wandering. pudgy mRNA levels measured by quantitative RT-PCR relative to rp49 for feeding (‘‘fL3’’) and wandering (‘‘wL3’’)
3rd instar larvae. For all panels, Error bars: Std. Dev., * ttest,0.05, ** ttest,0.01, ***ttest,0.001.
doi:10.1371/journal.pgen.1002478.g001
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Figure 2. Pudgy is an ACS localized to mitochondria influencing lipid oxidation. (A) Recombinant pudgy protein exhibits ACS activity in
vitro. Equal amounts of recombinant, commercial ACS from the Free Fatty Acids Quantification Kit (Biovision) (‘‘commercial ACS’’), purified
recombinant His-tagged pudgy protein (‘‘pudgy-His’’), or an equivalent amount of eluate from a parallel purification with bacteria not expressing
pudgy-His (‘‘negative control’’), were mixed with free fatty acids and CoA in vitro. The rate of synthesis of acyl-CoA is indicated. All ACS activities for
commercial ACS and pudgy-His were significantly above negative control background (ttest,0.05). (B) pudgy expression measured by Q-RT-PCR
relative to rp49 in various tissues of wildtype 3rd instar larvae, as indicated. SG: salivary gland. (C) Pudgy localizes to mitochondria.
Immunofluorescence micrograph of S2 cells transfected to express pudgy-HA (blue) and mito-GFP to mark mitochondria (green) shows very good co-
localization of the two proteins. Actin staining (red) delineates the cell outline. (Pearson’s correlation= 0.8460.04 on 8 images [50]). (D–D9) pudgy
expression, by Q-RT-PCR relative to rp49, in control w1118 or pdgy[BG] mutant feeding 3rd instar larvae (96 h AEL) (D) or adult males (D9). (E) Lipid
oxidation in pdgy[BG] mutants is impaired. Oxygen consumption rate, measured using a Clark electrode, is significantly reduced in pdgy[BG] mutant
larvae (light bars) compared to controls (dark bars) (*ttest = 0.03). This difference is abrogated in the presence of the CPT1 inhibitor etomoxir,
indicating it is due to a difference in lipid oxidation. (E9) pdgy[BG] mutants have significantly reduced CPTI-dependent oxygen consumption. CPTI-
dependent O2 consumption was calculated by subtracting the rate of oxygen consumption in the presence of 300 mM etomoxir (ie CPTI
independent) from the total rate of oxygen consumption in the absence of drug.
doi:10.1371/journal.pgen.1002478.g002
Insulin Regulates ACS Expression
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oxidation. Upon food removal, control flies progressively catab-
olized their triglyceride stores. After 6 hours of fasting, both
control larvae and control adult flies significantly reduced their
triglyceride stores (Figure 4B and 4B9, grey curves). Control larvae
reproducibly displayed an unexpected transient increase in stored
triglycerides after 2 hours of fasting before starting to deplete them
(Figure 4B). In contrast, pdgy[BG] mutants did not show any
reduction in triglyceride levels the first 6 hours of starvation
(Figure 4B and 4B9, black curves). Only as of 8 hours of starvation
did pdgy[BG] mutants start depleting their triglycerides stores,
completely depleting them by 36 hours of fasting (Figure 4B, 4B9
and Figure S3D), indicating that after an initial period, they were
nonetheless able to catabolize lipids. Similar defects could also be
observed by staining fat bodies of control and pdgy[BG] mutants
with Nile Red (Figure 4C). Interestingly, both the extended
survival upon food withdrawal as well as the delay in triglyceride
consumption the first 6 hours of fasting are also observed in
mutants for another gene involved in lipid catabolism - the fly
homolog of adipocyte triglyceride lipase, brummer [24,36].
To study lipid catabolism in pdgy[BG]mutants in more detail, we
performed quantitative lipidomic profiling of fed versus fasting
flies. Since the direct substrates of ACS action are free fatty acids,
Figure 3. Pudgy expression levels regulate organismal lipid homeostasis. (A–A9) pudgy overexpression causes leanness. Relative total body
triglycerides normalized to total body protein of wL3 larvae (A) or adults (A9) ubiquitously overexpressing pudgy from an inducible UAS-transgene
with the tubulin-GAL4 or actin-GAL4 drivers (tubG4..pudgy or actinG4.pudgy), or in the two control parental genotypes, which by themselves do
not overexpress pudgy (GAL4 only and UAS-pudgy only). (B–B9) pudgy mutants are fat. Relative total body triglycerides normalized to total body
protein of control or pdgy[BG] mutant wL3 larvae (B) or adult males (B9), as well as pdgy[BG] mutants simultaneously carrying UAS-pudgy. The
pdgy[BG] insertion is concurrently a loss-of-function insertion as well as a GAL4 gene trap. (C) Lipidomic profiling of control versus pdgy[BG] mutant
adult males. Many but not all triacylglyceride (TAG) species are significantly elevated in pudgy mutants. The 20 most abundant TAGs are indicated.
Values for each TAG are normalized to 1 in control animals. Numbers in parentheses indicate total carbon number of the combined fatty acid chains
and total level of desaturation, or values for each individual fatty acid when known. For all panels, Error bars: Std. Dev., *ttest,0.05, **ttest#0.01,
***ttest,0.001.
doi:10.1371/journal.pgen.1002478.g003
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Figure 4. pudgy mutants have an altered lipid catabolic profile upon fasting. (A) pdgy[BG] mutants have significantly improved survival
under starvation conditions. Control w1118 (dashed line) and pdgy[BG] (solid line) 3-day-old males starved on 0.8% agarose/PBS (n = 90, log rank
Insulin Regulates ACS Expression
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we first quantified free fatty acids in pdgy[BG] mutant and control
animals (Figure 4D). Upon starvation, levels of free C14:0, C16:0
and C16:1 drop in control animals (Figure 4D). Since levels of free
fatty acids reflect the balance between fatty acid lipolysis and fatty
acid ligation to CoA (Figure 1A), this indicates that upon starvation
ACSs become activated in order to handle the increased production
of free fatty acids coming from triglyceride lipolysis. In contrast, in
pdgy[BG] mutants, levels of free C14:0 and C16:0 remained
aberrantly high (Figure 4D), as expected from impaired ACS
activity in the pudgymutants. Defects were only apparent in a subset
of free fatty acids (Figure 4D) suggesting that the metabolism of all
fatty acids might not be affected equally by loss of pudgy in vivo.
We next performed quantitative lipidomic profiling to detect all
TAG species in fed versus fasting control and pdgy[BG] flies. Although
many TAG species are normally catabolized in pdgy[BG] mutants
(Table S2), some species are not. For instance, levels of TAG(39:1)
dropped in control animals upon fasting but remained elevated in
pdgy[BG]mutants (Figure 4E), whereas TAG(53:3) remained constant
in control animals but dropped in pdgy[BG] mutants (Figure 4E9).
Therefore, pudgy mutants display an altered profile in the catabolism
of lipid species. Consistent with this, pdgy[BG] mutants have aberrant
expression of a large number of putative lipases, elongases and ACSs
(Figure S4) suggesting that lipid catabolic pathways may be
readjusting in response to loss of pudgy. In sum, our data indicate
that pudgy mutants are initially defective in the catabolism of fatty
acids, but after an initial period are able to catabolize all triglycerides,
albeit with a different pattern compared to controls.
Pudgy mutants also display insulin signaling and
carbohydrate metabolism phenotypes
Interestingly, although Pudgy is an enzyme involved in lipid
metabolism, we found that pudgy mutants also have a number of
other non-lipid phenotypes. Pudgymutants had significantly reduced
expression of insulin-like peptides (Figure 5A and 5A9). Corre-
spondingly, they had elevated expression of 4E-BP, a direct FOXO
target, consistent with reduced insulin signaling in these animals
(Figure 5A and 5A9). Pudgy mutants also have two phenotypes
associated with reduced insulin signaling: they are mildly, but
significantly reduced in size compared to controls (Figure 5B and
5B9) and they are long-lived (Figure 5E). In addition, pudgy mutants
also have reduced glycogen stores (Figure 5C and 5C9) and
increased circulating sugars (Figure 5D and 5D9) suggesting elevated
mobilization of carbohydrates. Conversely, pudgy overexpression
leads to reduced circulating sugars (Figure 5F). Although these
phenotypes are not the focus of this story, and we do not know their
underlying molecular mechanisms, they are worth noting as they
probably represent crosstalk mechanisms in pdgy[BG] animals
caused by their elevated lipid stores and reduced lipid oxidation,
of interest for future studies.
Expression of ACSs is also regulated by insulin signaling
in mammals
We next asked whether our two central observations from
Drosophila—that insulin signaling regulates ACS expression and
that ACS expression levels are important for lipid homeostasis—
can also be observed in a mammalian context. To this end, we
treated three different cell types, 3T3-L1 adipocytes, Hepa1.6
hepatocytes and C2C12 myotubes, representing three different
tissues of metabolic importance, in the presence or absence of
insulin, and measured by quantitative RT-PCR the expression of
all medium-chain, long-chain and very-long-chain ACSs. Report-
ed in Figure 6 are the ACSs who’s transcription was regulated in a
manner similar to that of pudgy, i.e. repressed by insulin. In
addition, other ACSs were either not transcriptionally regulated by
insulin, or were induced by insulin (Table S3A and S3B). In 3T3-
L1 adipocytes, expression of six different ACSs was up-regulated
upon removal of serum (Figure 6A). This up-regulation was
suppressed if insulin was supplied upon serum removal, indicating
that the up-regulation was specific for insulin signaling (Figure 6A).
In particular, expression of ACSL4 increased very strongly, 12-
fold, within the short 1-hour time window of serum removal
(Figure 6A). Likewise, expression of 6 different ACSs increased in
an insulin-dependent manner in Hepa1.6 hepatocytes upon serum
removal, with ACSVL5 increasing 13-fold (Figure 6B). Although
some ACSs are similarly regulated by insulin in both cell types,
such as ACSL1, other ACSs are specifically regulated in one cell
type or the other, probably reflecting the specific function of each
tissue. Finally, a number of ACSs were also regulated by insulin in
C2–C12 myotubes (Figure 6C). (Since C2–C12 myoblasts are
differentiated into myotubes by culturing in low-serum conditions,
the ‘control’ and ‘serum-deprived’ conditions are similar in gene
expression.)
To test whether the level of expression of ACSs in 3T3-L1
adipocytes affects lipid homeostasis, we knocked down expression
of three different ACSs – ACSL1, ACSL3 and ACSL4.
Knockdown of ACSL1 and ACSL3 using siRNAs caused reduced
triglyceride storage in differentiated 3T3-L1s (Figure 6D) in a
manner that correlated with relative knock-down efficiency (Figure
S5A, S5B). This is consistent with previous reports that ACSL1
promotes fatty acid uptake and incorporation into TAG in 3T3-
L1s [37,38]. Using a different approach, 3T3-L1s expressing an
shRNA targeting ACSL4 also had reduced triglyceride storage
(Figure 6E and Figure S5C).
Discussion
ACS expression regulates organismal lipid homeostasis
Fatty acid (FA) catabolism represents an important energy
yielding mechanism for cells and organisms, contributing up to
50–60% of a person’s energy expenditure under aerobic exercise
conditions [39]. Fatty acid catabolism can be envisioned in two
steps (Figure 6F). First, fatty acids are mobilized from stored
triacylglycerols (TAG) via the activity of lipases to yield free fatty
acids. Second, the free fatty acids are oxidized, yielding energy.
Traditionally, textbook knowledge considers the first step –
mobilization via lipases – to be the important regulated step.
However, several lines of reasoning suggest that lipolysis cannot be
the only important regulated event in the fatty acid catabolic
P= 361028). (B–B9) pdgy[BG] mutants display delayed lipid catabolism upon starvation. Relative total body triglycerides normalized to total body
protein of control and pdgy[BG] L2 larvae (84 h AEL) (B) or adults (B9) fasted for 0, 2, 4, 6 or 8 hours. (C) Nile red staining of early L3 larval fat bodies
reveals larger lipid droplets in pdgy[BG] mutants compared to controls, both under fed conditions and when starved for 24 h on 0.8% agarose/PBS.
Scare bars: 50 mm. (D) Pudgy mutants have aberrant levels of free fatty acids. Free fatty acid levels obtained by lipidomic profiling of control and
pdgy[BG] mutant adults under fed and 16-hour fasting (‘‘starved’’) conditions. Measurements annotated with different letters are significantly
different from each other (ttest,0.01). # indicates lipid species for which the drop in concentration observed in control animals upon fasting is
significantly impaired in the mutant. (E–E9) pdgy[BG] mutants have an altered profile of lipid catabolism upon fasting. Levels of TAG(39:1) (E) and
TAG(53:3) (E9) were quantified by UPLC-MS lipidomic profiling of control or pdgy[BG] mutant adult males after 0 and 16 hours of fasting. For all
panels, assays done in triplicate, Error bars: Std. Dev., * ttest,0.05, ** ttest#0.01, ***ttest,0.001.
doi:10.1371/journal.pgen.1002478.g004
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Figure 5. Pudgy mutants have reduced insulin signaling and carbohydrate metabolism defects. (A–A9) Pudgy mutant feeding L3 larvae
(96 h AEL) (A) and adults (A9) have reduced expression of ILPs, and elevated expression of 4E-BP, a gene suppressed by insulin signaling. Assayed by
quantitative RT-PCR relative to rp49. (B–B9) Pudgy mutants are mildly reduced in size. Weight of control (w1118) and pdgy[BG] wL3 larvae (B) or adult
males (B9). (C–C9) Pudgymutants have reduced glycogen stores. Total body glycogen normalized to total body weight for wL3 larvae (C) or adults (C9).
(D–D9) Pudgy mutants have elevated levels of circulating sugars. Relative trehalose levels of control and pdgy[BG] mutant wandering 3rd instar larvae
(D) or adults (D9). (E) pdgy[BG] mutants have extended lifespan. Lifespan of control (dotted line) or pdgy[BG] mutant (black line) males, reared under
controlled growth conditions and maintained on normal laboratory food (30 flies per tube, in octuplicate, log rank P= 10215). (F) Pudgy
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pathway. Firstly, liberation of free fatty acids from TAG does not
necessarily channel them towards beta-oxidation. Free fatty acids
can have several fates, including not only beta-oxidation but also
fatty acid elongation (yielding very long chain fatty acids) and re-
esterification to generate complex lipids including TAG [40,41].
In fact, a large fraction of FAs liberated from TAG participate in a
overexpression causes hypoglycemia. Relative trehalose levels normalized to total body weight of wandering 3rd instar larvae ubiquitously
overexpressing pudgy from an inducible UAS-transgene with the actin-GAL4 driver (actinG4..pudgy) or in the two control parental genotypes,
which by themselves do not overexpress pudgy (actinG4/+ and UAS-pudgy/+). For all panels unless noted, assays done in triplicate, Error bars: Std.
Dev., *ttest,0.05, **ttest#0.01, ***ttest#0.001.
doi:10.1371/journal.pgen.1002478.g005
Figure 6. Expression of many ACSs is regulated by insulin in mammals, and their expression level affects lipid homeostasis. (A–C)
Expression of selected Acyl-CoA synthetases in 3T3-L1 adipocytes (A), Hepa1.6 hepatoma cell line (B) or C2–C12 myotubes (C) treated with complete
DMEM (control), DMEM lacking serum (2FBS), or DMEM lacking serum but supplemented with 5 mg/mL insulin (2FBS+insulin). Cells were serum
starved for 1 hour (3T3-L1) or for 4 hours (Hepa1.6 and C2C12), and then treated with or without insulin (5 mg/ml for 3T3-L1 and Hepa1.6, 100 nM for
C2C12) for 1 (3T3-L1 and Hepa1.6) or 2 hours (C2C12). Expression was measured by quantitative RT-PCR normalized to beta-actin. Since C2–C12
myotubes are differentiated by culturing in medium with low serum, the control and –FBS conditions are similar. Stars indicate statistical significance
relative to control (3T3-L1, Hepa1.6) or to –FBS (C2C12). (D) Knockdown of ACSL1 or ACSL3 expression causes reduced triglyceride levels in
differentiated 3T3-L1s. Relative total triglycerides normalized to total protein for 3T3-L1 cells treated with control siRNA (scambled) or siRNA targeting
ACSL1 (ACSL1-1 and ACSL1-2) or ACSL3 shortly prior to differentiation. (E) Knockdown of ACSL4 expression causes reduced triglyceride levels in
differentiated 3T3-L1 cells. Relative total triglycerides normalized to total adiponectin levels, a marker for differentiation, for control 3T3-L1s or 3T3-
L1s treated with shRNA targeting ACSL4. (F) Simplified schematic representation of fatty acid metabolism. Fatty acids cycle between a free form (FFA)
and a stored form as triacylglycerol (TAG). FFA are released from TAG by the action of lipases, wherease FFA are re-esterified via the sequential action
of a subset of acyl-CoA synthetases and acyl-transferases. Neither lipases nor acyl-transferases can create or destroy fatty acids. Fatty acids are
destroyed via the action of acyl-CoA synthetases which activate them for beta-oxidation. For all panels, assays done in triplicate. Error bars: std. dev.
* ttest,0.05, **ttest,0.01, ***ttest,0.001.
doi:10.1371/journal.pgen.1002478.g006
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‘futile’ cycle, being re-esterified to generate new TAG [42].
Quantitative estimates of the triglyceride/fatty acid cycle in
humans and in animals show that only a small fraction of the FFA
released as a result of lipolysis in adipose tissue are oxidized, and
the majority are re-esterified to triglycerides in various tissues [43].
Secondly, elevated levels of free FA are believed to be deleterious
to animals, causing lipotoxicity and contributing towards insulin
resistance [40]. Therefore, increased FA levels due to increased
lipolysis without concurrent upregulation of downstream bio-
chemical pathways might actually be noxious to the animal. We
identify here the subsequent step in fatty acid catabolism -
coupling of fatty acids to CoA via ACSs - as an additional,
important regulated step in lipid catabolism. A priori, it was
possible that the level of expression of pudgy in vivo was not limiting
for lipid oxidation, and that lipid catabolism in Drosophila is only
regulated by availability of free fatty acids via lipolysis. However,
our data suggest this is not the case. Both a reduction and an
increase in pudgy levels effects total lipid levels in the fly (Figures 3A,
3A9, 3B, 3B9), indicating that regulation of pudgy levels contributes
significantly to total body lipid homeostasis. This makes sense in
light of the fact that free fatty acids can have multiple different
fates once released from triglycerides, such as beta-oxidation or re-
esterification to form triglycerides. Therefore the relative activities
of biochemical reactions downstream of lipolysis are important for
determining the fate of the released fatty acids. In particular, the
balance in expression and activity of ACSs that activate fatty acids
for beta-oxidation versus lipid biosynthesis may be of particular
importance. In Drosophila, upon starvation, FOXO upregulates
expression of the fly adipocyte triglyceride lipase homolog,
brummer [24]. By upregulating expression of both brummer
and pudgy, FOXO mounts a concerted effort towards channeling
fatty acids from their stored form towards beta-oxidation.
It may appear surprising that blocking fatty acid ß-oxidation via
mutation of pudgy leads to increased TAG levels in the animal,
since lipolysis is often considered to be the key step in regulating
TAG levels. Indeed, via the actions of lipases and acyl-transferases,
fatty acids cycle between a free form and a stored TAG form
(Figure 6F), however neither of these enzymatic activities either
creates or destroys fatty acids. The steady-state level of fatty acids
in an organism depends only on the relative balance of fatty acid
synthesis/uptake versus fatty acid oxidation. Therefore, reducing
ß-oxidation increases total organismal fatty acids. Since free fatty
acids are in equilibrium with the stored TAG form, this entails an
increase in TAG levels (Figure 6F).
An alternate interpretation of our data is that the observed delay
in TAG consumption reflects a reduced global metabolic rate
caused indirectly by lack of pudgy activity. We believe this
interpretation is unlikely, because a global redution in metabolic
rate would be expected to lead to a concomitant increase in the
levels of both stored lipids and stored carbohydrates (ie glycogen).
Pudgy mutants, however, have elevated lipids levels but reduced
glycogen levels, suggesting a lipid-specific defect in accordance
with pudgy’s ACS function.
Insulin/IGF signaling regulates lipid homeostasis in part
via ACS expression
Insulin/IGF signaling is known to control lipid biosynthesis in
part via SREBP1, and lipid catabolism via regulation of lipases
such as hormone sensitive lipase and via decreasing the rate of
fatty acid entry into mitochondria [15,44,45]. We identify here the
ACS CG9009/pudgy as one molecular link between the insulin
signaling pathway and lipid catabolism in Drosophila. We find
that pudgy is a transcriptional target gene of the insulin pathway
which is directly regulated by FOXO. By repressing pudgy
expression, insulin blocks the channeling of fatty acids towards
the beta-oxidative pathway. Insulin has been reported to induce
expression of two ACSs in mammals - ACSL5 via a mechanism
involving SREBP1c [46], and ACSL6 via an unknown mechanism
[47] – however to our knowledge pudgy is the first example of an
ACS which is repressed by insulin. Likewise, although pudgy
belongs to a clade of ACSs that does not also include human
paralogs, we identify a number of human ACSs that are
transcriptionally repressed by insulin in mammalian cells,
analogously to pudgy.
Pudgy mutants have altered metabolic parameters
We find that pudgy mutants have a significant number of
metabolic alterations. For instance, in addition to the changes in
lipid metabolism, we find that pudgy mutants have reduced
glycogen stores and increased circulating sugars. Although the
underlying mechanism is unclear, one plausible explanation is that
pudgy mutants need to rely more on glucose mobilization to
maintain cellular energy levels, to compensate for reduced fatty
acid beta-oxidation, which is normally a significant energy source.
We also find that pudgy mutants have a different profile of lipid
homeostasis and starvation-induced catabolism compared to
controls. Under fed conditions, some lipid species in pudgy mutants
are highly elevated, such as TAG(50:1) which is almost 3-fold the
normal levels, whereas others such as TAG(42:0) are unperturbed
(Figure 3C). Likewise, during starvation, the catabolism of lipid
species is altered, with some TAGs being catabolized more readily
and some less readily compared to controls (Figure 4E and 4E9).
Fatty acid species are linked to each other via a complex network
of biochemical pathways involving saturases, desaturases, elon-
gases, ACSs, lipases, etc. This ‘landscape’ of lipid species is clearly
perturbed by removal of pudgy. This perturbation might be partly a
direct consequence of loss of pudgy, and partly an attempt of the
system to compensate. Indeed, at the gene expression level, a very
large proportion of genes with putative functions in fatty acid
metabolism are altered in pudgy mutants, suggestive of compen-
satory mechanisms (Figure S4). For instance, the elongase eloF is
more than 2-fold up-regulated in the pudgy mutant, and the ACS
CG6432 is dramatically down-regulated.
In sum, we identify here the ACS pudgy as a transcriptional
target of insulin signaling, and show that modulation of pudgy
expression levels causes changes in steady-state lipid levels in the
fly. Mammalian tissue culture experiments suggest similar
mechanism may be at work in mammalian cells.
Materials and Methods
Constructs and fly strains
A list of oligos used for clonings and quantitative PCRs can be
found in Supplemental Materials & Methods (Text S1). Additional
oligos sequences are available upon request. UAS-pudgy was
generated by cloning the CG9009 coding sequence, obtained by
RT-PCR as an XhoI-XbaI fragment, into the XhoI-XbaI sites of
pUAST. The mito-GFP ORF, encoding the 31 amino acid
mitochondrial import sequence from human cytochrome C
oxidase subunit VIII fused to the N terminus of GFP, was
amplified from flies carrying mito-GFP (Bloomington Stock
Center, [48]) and cloned into pCasper4 carrying a tubulin
promoter. For luciferase assays, the FOXO enhancer region of
pudgy intron 1 was amplified as a KpnI-KpnI fragment and cloned
into the KpnI site of a luciferase plasmid containing the Adh basal
promoter, described in [20]. Remaining constructs for the FOXO
luciferase assay were described previously [20]. FOXO21 and
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FOXO25 flies [23]; P{GT1}BG02662 flies and actin-GAL4 flies
(Bloomington Stock Center).
Controlled growth conditions for metabolic and
longevity analyses
For all metabolic, respiratory, and longevity analyses, animals
were reared under strictly controlled growth conditions. Eggs were
collected on apple plates, and newly hatched L1 larvae were
seeded in vials at a density of 60/vial and grown at 25uC without
yeast supplementation. Adult flies were then aged 3 days for
analysis. All assays were done in triplicate. Our fly food recipe is as
previously reported [49]. Metabolic, starvation and longevity
assays were performed as in [40] and as detailed in Text S1
(Supplemental Materials and Methods).
Lipidomics analysis
Growth controlled w1118 and pdgy[BG] mutant males were aged
3 days, and then fed normal food or starved on 0.8% agarose/PBS
overnight (16 hours). The flies were frozen in liquid nitrogen and
cryo-dried. The samples were then analyzed by UPLC-QTof-MS
using an Acquity BEH C18 (1.7 mm 2.16100 mm) column and
electrospray ionization in positive ion mode. Details are provided
in the Supplemental Materials & Methods (Text S1).
In vitro ACS activity assay
His-tagged pudgy protein was obtained by cloning the coding
sequence into pET23d, expressing it in BL21 E. coli, and purifying
it using Ni-NTA Agarose beads (Qiagen). 4.2 mg of recombinant
pudgy-His, or an equivalent amount of eluate from a parallel
purification using bacteria not expressing pudgy-His (circa
4.3 mg), were added into reaction buffer (50 mM Tris–HCl
pH 7.8, 10 mM sodium acetate, 4 mM ATP, 0.15 mM CoA,
1 mM magnesium chloride, 10 mM DTT) with 10 nmol free fatty
acid. After incubated at 37C for 30 min, the synthesized acyl-CoA
was detected using the Free Fatty Acids Quantification Kit
(Biovision), omitting the ACS incubation step. As a positive
control, 4.2 mg of ACS supplied with the kit was used.
Oxygen consumption measurements
Growth-controlled, wandering third instar larvae were cleaned
in cold PBS, dried on filter paper and weighed. Larvae were then
dissected into ice-cold BIOS buffer (2.77 mM CaK2EGTA,
7.23 mM K2EGTA, 5.77 mM Na2ATP, 6.56 mM MgCl2?6H2O,
20 mM Taurine, 15 mM Na2Phospho-creatine, 20 mM Imidaz-
ole, 0.5 mM DTT, 50 mMMES) and subsequently permeabilized
with 4 mM digitonin in BIOS buffer for 15 min at 4uC in a
shaker. Tissues were then resuspended in ice-cold FAO medium
(110 mM NaCl, 4.7 mM KCl, 2 mM MgSO4, 1.2 mM
Na2HPO4, 2.5 mM glucose adjusted to pH 7.4, supplemented
with 0.5 mM carnitine). Oxygen consumption was measured using
a Clark electrode and normalized to animal body weight.
Etomoxir was added (50 mM or 300 mM) to block acyl-CoA
transport via CPTI.
Detailed procedures
Detailed procedures of methods used are included in the
Supplemental Materials & Methods (Text S1).
Supporting Information
Figure S1 Pudgy overexpression is sufficient to increase lipid
beta-oxidation rates. (A) CPTI-dependent O2 consumption,
calculated by subtracting the rate of oxygen consumption in the
presence of 300 mM etomoxir (ie CPTI independent) from the
total rate of oxygen consumption in the absence of drug, is
indicated for larval tissues from three genotypes: two parental
genotypes which do not overexpress pudgy (Tubulin-GAL4/+.
and UAS-pudgy/+) and the experimental genotype which
ubiquitously expresses Pudgy (Tubulin-GAL4/UAS-Pudgy).
(TIF)
Figure S2 pdgy[BG] mutants are normally developed and fatter
in all development stages. (A) Image of growth-controlled, 3 day
old, pudgy mutant and control male flies. Mutant flies have no
detectable patterning defects. (B) pudgy mutants are fat at all stages
of development. Relative total body triglycerides normalized to
total body protein of control or pdgy[BG] mutant males at
wandering 3rd instar stage (wL3), or at 2, 4 and 10 days after
adult eclosion (D2, D4 and D10 respectively). For all panels, assays
done in triplicate. Error bars: Std. Dev. ***ttest,0.001.
(TIF)
Figure S3 Pudgy mutants do not eat more than controls, and
have reduced expression of lipogenic genes. (A–A9) Food intake of
pdgy[BG] mutants is not elevated compared to controls, both in
larvae (96 h AEL) (A) and in 3-day old adults (A9). Food was
supplemented with 0.5% Blue 9 dye, and ingested food per animal
was quantified. n= 6, done in triplicate. (B–B9) pdgy[BG] mutant
3rd instar larvae (96 h AEL) (B) and adults (B9) do not have
elevated expression of acetyl-CoA carboxylase (dACC), or Fatty
Acid Synthase (dFAS, CG3523). Assayed by quantitative RT-PCR
relative to rp49. (C) pdgy[BG] mutants have significantly improved
survival under starvation conditions. Control w1118 (dashed line)
and pdgy[BG] (solid line) L2 larvae (72 h after egg laying) were
starved on 0.8% agarose/PBS (n = 90, log rank P=961028). (D)
Relative total body triglycerides normalized to total body protein
of control and pdgy[BG] adult males, fasted for 0, 12, 24 or
36 hours. In all panels, *ttest,0.05, **ttest,0.01, ***ttest,0.001.
(TIF)
Figure S4 Expression of lipases, elongases, desaturases and
ACSs in control and pudgy mutants upon feeding and fasting.
Expression of multiple putative lipases (A), elongases and
desaturases (B) and ACSs (C) is significantly altered in pdgy[BG]
mutants both under fed and fasted conditions. Data are from L3
larvae (96 hours AEL), starved on 0.8% agarose/PBS for 4 hours.
Gene expression was measured by quantitative RT-PCR relative
to rp49. Genes in (A) and (B) were selected based on Flybase Gene
Ontology annotations, and genes in (C) are the complete set of
ACSs identified in [27]. In all panels, *ttest,0.05, **ttest,0.01,
***ttest,0.001.
(TIF)
Figure S5 Knockdown efficiency of siRNAs for mouse ACSs.
Knock-down efficiency in differentiated 3T3-L1s treated with
siRNAs targeting ASCL1 (A) and ACSL3 (B) shortly prior to
differentiation or with shRNA targeting ACSL4 (C). Targeted
genes were analyzed by Q-PCR normalized to ß-actin. For all
panels, assays done in triplicates. Error bars: Std. Dev.,
*ttest,0.05, **ttest,0.01, ***ttest,0.001.
(TIF)
Table S1 Lipidomic profile of pudgy[BG] mutant and control
animals. Lipid levels, in mg lipid per mg protein, in 3-day old
control and pudgy[BG] mutant males. Average values and standard
deviation for triplicate biological replicates are indicated, as well as
the student t-test p-value indicating significance of the difference
between controls and mutants. Values in parenthesis in the lipid
names indicate the total number of carbons in the fatty acids
chains, and the total level or desaturation. Ceramide (Cer),
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Cholesterol ester (ChoE), Diacylglycerol (DG), Lyso-Phosphati-
dylcholine (LysoPC), Monoacylglycerol (MG), Phosphatidic Acid
(PA), Phosphatidylcholine (PC), Phosphatidylethanolamine (PE),
Phosphatidylglycerol (PG), Phosphatidylserine (PS), Sphingomy-
elin (SM), Triacylglycerol (TG).
(PDF)
Table S2 TAG catabolism in pudgy[BG] mutant and control
animals after 16 hours starvation. Lipid levels, in mg lipid per mg
protein, in 3-day old control and pudgy[BG] mutant males starved
for 0 or 16 hours. Average values and standard deviation for
triplicate biological replicates are indicated. Values in parenthesis
in the lipid names indicate the total number of carbons in the fatty
acids chains, and the total level or desaturation. Ceramide (Cer),
Cholesterol ester (ChoE), Diacylglycerol (DG), Lyso- Phosphati-
dylcholine (LysoPC), Monoacylglycerol (MG), Phosphatidic Acid
(PA), Phosphatidylcholine (PC), Phosphatidylethanolamine (PE),
Phosphatidylglycerol (PG), Phosphatidylserine (PS), Sphingomy-
elin (SM), Triacylglycerol (TG).
(PDF)
Table S3 Expression of mouse ACSs in Hepa1.6 and 3T3-L1
cells in response to serum removal (‘‘2FBS’’), or serum removal
supplemented with insulin (‘‘2FBS+insulin’’) as in Figure 6 of the
main text.
(PDF)
Text S1 Supplemental Materials and Methods.
(DOC)
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